Australia provisionally approves oral COVID-19 pills by Merck & Pfizer

COVID19 |  News | 0 Comment | 21 Jan, 2022

The Therapeutic Goods Administration (TGA) in Australia has issued provisional approval of the first oral treatments for...Read more

Australia pitches $24 M for telehealth to tackle growing cases of omicron

COVID19 |  News | 0 Comment | 18 Jan, 2022

As Omicron case numbers grow, the Australian Government will make temporary changes to Telehealth to give general p...Read more

Australia gives recognition to Sputnik V vaccine for international travel

COVID19 |  News | 0 Comment | 17 Jan, 2022

The Therapeutic Goods Administration (TGA) in Australia has determined that an additional COVID-19 vaccine, the two dose...Read more

Singapore recommends booster dose at no later than 9 months

COVID19 |  News | 0 Comment | 06 Jan, 2022

The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore recommends that all vaccinated persons aged 18 years a...Read more

T-cell responses by vaccines and boosters effective against Omicron: Australian study

COVID19 |  News | 0 Comment | 03 Jan, 2022

Research from the University of Melbourne in Australia and Hong Kong University of Science and Technology (HKU...Read more

Japan-funded study explores antibodies to neutralise omicron

COVID19 |  News | 0 Comment | 28 Dec, 2021

An international team of scientists have identified antibodies that neutralize omicron and other SARS-CoV-2 variants. Th...Read more

Nasal spray to fight COVID-19 heads to clinical trial in Australia

COVID19 |  News | 0 Comment | 24 Dec, 2021

An at-home nasal spray treatment for COVID-19 will be put to the test by Melbourne biomedical researchers, as the Univer...Read more

New Zealand approves use of Ronapreve to prevent & treat COVID-19

COVID19 |  News | 0 Comment | 23 Dec, 2021

The Ministry of Health’s medicine regulatory arm Medsafe in New Zealand has approved a new COVID-19 medicine Ronap...Read more

Hong Kong develops first anti-COVID-19 stainless steel

COVID19 |  News | 0 Comment | 23 Dec, 2021

A team of researchers at the Department of Mechanical Engineering of the Faculty of Engineering of the University of Hon...Read more

Australia updates COVID-19 calculator for Pfizer vaccine efficacy

COVID19 |  News | 0 Comment | 22 Dec, 2021

The University of Queensland in Australia has updated a calculator to help people understand their risk factors for COVI...Read more

Any New Way to Track Omicron Besides the Sequencing?

COVID19 |  News | 0 Comment | 16 Dec, 2021

  WHO has officially appealed to countries that they must enhance surveillance & sequencing efforts to curb Om...Read more

Fapon Biotech Introduces POCT Test Solution for SARS-CoV-2 Omicron Variant Identification

COVID19 |  News | 0 Comment | 15 Dec, 2021

Omicron variant has showed surging cases in nearly 77 countries around the world in less than one month and seems to bec...Read more

Singapore extends use of Pfizer vaccine for children of age 5 to 11

COVID19 |  News | 0 Comment | 13 Dec, 2021

The Health Sciences Authority (HSA) in Singapore has extended the authorisation of Comirnaty COVID-19 vaccine by Pfizer-...Read more

Hong Kong studies impact of Pfizer vaccine on Omicron variant

COVID19 |  News | 0 Comment | 13 Dec, 2021

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...Read more

$540 M to continue and expand Australia’s COVID-19 response

COVID19 |  News | 0 Comment | 08 Dec, 2021

The Australian government has invested a further $540 million in response to the COVID-19 pandemic including significant...Read more

Korea offers niclosamide-based drug as possible cure for COVID-19 variants

COVID19 |  News | 0 Comment | 08 Dec, 2021

Experimental results have been published for the first time showing that an antiviral drug containing niclosamide, an an...Read more

Singapore secures additional supply of mAb sotrovimab for COVID-19 treatment

COVID19 |  News | 0 Comment | 07 Dec, 2021

GlaxoSmithKline (GSK) Singapore has announced an agreement with the Government of Singapore to supply additional doses o...Read more

COVID-19: A Crash Course on ‘The Art of Living’!

COVID19 |  Opinion | By Dr Ashok Kumar, President – Centre for Research & Development, Ipca Laboratories | 0 Comment | 06 Dec, 2021

Most of our life time efforts are bound in securing a good future, but time and again it has been proved that it is not ...Read more